Life insurtech YuLife has raised a further $120m (£95m) through a Series C funding spearheaded by investor Dai-ichi Life.
The latest funding round takes the provider's total capital to $206m (£172m) since it was founded in 2016, having received support from investors such as Creandum, LocalGlobe, Target Global, Latitude, Anthemis, OurCrowd, Notion, MMC and Eurazeo. Last July, YuLife secured £50.6m through its Series B funding round to develop new products and expand its market growth. This year's funds will be used to broaden YuLife's reach into global markets and upscale its product range. Its current proposition is built upon rewards and benefits to employees for wellness activities and healthy habi...
To continue reading this article...
Join COVER for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.
